» Articles » PMID: 37077909

Loss of NLRP3 Reduces Oxidative Stress and Polarizes Intratumor Macrophages to Attenuate Immune Attack on Endometrial Cancer

Overview
Journal Front Immunol
Date 2023 Apr 20
PMID 37077909
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The interaction between endometrial cancer (EMC) cells and intratumoral macrophages plays a significant role in the development of the disease. PYD domains-containing protein 3 (NLRP3) inflammasome formation triggers caspase-1/IL-1β signaling pathways and produces reactive oxygen species (ROS) in macrophages. However, the role of NLRP3-regulated ROS production in macrophage polarization and the subsequent growth and metastasis of EMC remains unknown.

Methods: We conducted bioinformatic analysis to compare NLRP3 levels in intratumoral macrophages from EMC and normal endometrium. experiments involved knocking out NLRP3 in macrophages to shift the polarization from an anti-inflammatory M1-like phenotype to a proinflammatory M2-like phenotype and reduce ROS production. The impact of NLRP3 depletion on the growth, invasion, and metastasis of co-cultured EMC cells was assessed. We also evaluated the effect of NLRP3 depletion in macrophages on the growth and metastasis of implanted EMC cells in mice.

Results: Our bioinformatic analysis showed significantly lower NLRP3 levels in intratumoral macrophages from EMC than those from normal endometrium. Knocking out NLRP3 in macrophages shifted their polarization to a proinflammatory M2-like phenotype and significantly reduced ROS production. NLRP3 depletion in M2-polarized macrophages increased the growth, invasion, and metastasis of co-cultured EMC cells. NLRP3 depletion in M1-polarized macrophages reduced phagocytic potential, which resulted in weakened immune defense against EMC. Additionally, NLRP3 depletion in macrophages significantly increased the growth and metastasis of implanted EMC cells in mice, likely due to compromised phagocytosis by macrophages and a reduction in cytotoxic CD8+ T cells.

Discussion: Our results suggest that NLRP3 plays a significant role in regulating macrophage polarization, oxidative stress, and immune response against EMC. NLRP3 depletion alters the polarization of intratumoral macrophages, leading to weakened immune defense against EMC cells. The reduction in ROS production by the loss of NLRP3 may have implications for the development of novel treatment strategies for EMC.

Citing Articles

Advances in S100 protein family for gynecological malignancies.

Wu S, Xu J Discov Oncol. 2025; 16(1):287.

PMID: 40057924 PMC: 11891126. DOI: 10.1007/s12672-025-02028-x.


Probiotic-Derived Metabolites from OC01 Reprogram Tumor-Associated Macrophages to an Inflammatory Anti-Tumoral Phenotype: Impact on Colorectal Cancer Cell Proliferation and Migration.

Garavaglia B, Vallino L, Ferraresi A, Amoruso A, Pane M, Isidoro C Biomedicines. 2025; 13(2).

PMID: 40002754 PMC: 11853712. DOI: 10.3390/biomedicines13020339.


Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis.

Ma R, Zheng Y, Wang J, Xu H, Zhang R, Xie Z Front Oncol. 2024; 14:1387860.

PMID: 39650066 PMC: 11620973. DOI: 10.3389/fonc.2024.1387860.


Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy.

Surve D, Fish A, Debnath M, Pinjari A, Lorenzana A, Piya S Nat Commun. 2024; 15(1):9035.

PMID: 39426974 PMC: 11490495. DOI: 10.1038/s41467-024-53396-x.


Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.

Al Mamun A, Geng P, Wang S, Shao C J Inflamm Res. 2024; 17:7037-7056.

PMID: 39377044 PMC: 11457779. DOI: 10.2147/JIR.S486878.


References
1.
Gao J, Liang Y, Wang L . Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. Front Immunol. 2022; 13:888713. PMC: 9280632. DOI: 10.3389/fimmu.2022.888713. View

2.
Boutilier A, Elsawa S . Macrophage Polarization States in the Tumor Microenvironment. Int J Mol Sci. 2021; 22(13). PMC: 8268869. DOI: 10.3390/ijms22136995. View

3.
Makker V, MacKay H, Ray-Coquard I, Levine D, Westin S, Aoki D . Endometrial cancer. Nat Rev Dis Primers. 2021; 7(1):88. PMC: 9421940. DOI: 10.1038/s41572-021-00324-8. View

4.
Rodriguez A, Blanchard Z, Maurer K, Gertz J . Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer. 2019; 10(2-3):51-63. PMC: 6542701. DOI: 10.1007/s12672-019-0358-9. View

5.
Ning C, Xie B, Zhang L, Li C, Shan W, Yang B . Infiltrating Macrophages Induce ERα Expression through an IL17A-mediated Epigenetic Mechanism to Sensitize Endometrial Cancer Cells to Estrogen. Cancer Res. 2016; 76(6):1354-66. DOI: 10.1158/0008-5472.CAN-15-1260. View